In the initial discovery of a drug, it can take cancer researchers up to two years to narrow down 10,000 molecules to find ...

SIGN UP TO CONTINUEPrint Subscriber? Sign Up for Full Access!Please sign up for as low as 36 cents per day to continue ...

After months of grueling cancer treatment, one little boy is finally back home at Fort Novosel. Months ago, before the sun ...

On September 3, OBX-115, a novel TIL therapy, was granted FDA regenerative medicine advanced therapy (RMAT) designation in ...

1st Class Kristina Soroka, SERE NCOIC and Joseph’s Mom. At the end of 2023, Joseph was diagnosed with an Atypical Teratoid Rhabdoid Tumor, a form of brain and spine cancer. He has spent the 8 ...

Lantern Pharma has won a trio of rare-pediatric-disease designations from the Food and Drug Administration for its investigational drug candidate LP-184 in multiple ultra-rare children's cancers.

Lafayette based House of Heat Pro Wrestling pulled out all the moves and slams for young wrestling fan after battle with ...

They picked the Masciantonio family of Moon Township. Their daughter, Emmy, has an atypical teratoid rhabdoid tumor, a very rare and extremely aggressive form of brain cancer. “We’ve had so ...

and for atypical teratoid / rhabdoid tumours in June 2022 and July 2022, respectively. Kazia is also developing EVT801, a small-molecule inhibitor of VEGFR3, which was licensed from Evotec SE ...

It’s been a tough journey for this family. In December of last year, he was diagnosed with an Atypical Teratoid Rhabdoid Tumor, a form of brain and spine cancer. “He got admitted to the ...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the... DALLAS, July 10, 2024--Lantern Pharma (NASDAQ: LTRN), a clinical-stage ...